Clinical Trials Browser

Phase 2 × enzastaurin × Tumor-Agnostic × Clear all

NCT00309140 2020-06-26

An Open Label Study of Oral Enzastaurin in Participants With Cancer

Phase 2 Completed

23 enrolled 13 charts

Neoplasms